Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

Richard B. Lipton, M. E. Bigal, K. B. Kolodner, P. B. Gorelick, K. Wilks, M. Schoebelock, G. Davidai

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

Original languageEnglish (US)
Pages (from-to)1099-1101
Number of pages3
JournalNeurology
Volume63
Issue number6
DOIs
StatePublished - Sep 29 2004

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination'. Together they form a unique fingerprint.

  • Cite this

    Lipton, R. B., Bigal, M. E., Kolodner, K. B., Gorelick, P. B., Wilks, K., Schoebelock, M., & Davidai, G. (2004). Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. Neurology, 63(6), 1099-1101. https://doi.org/10.1212/01.WNL.0000138494.66691.07